Director, Segment Marketing & Market Development

Foster City, CA (On-site)

$190K/yr – $240K/yrDirector/ExecutiveFull time

Posted 7 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own market narratives and segment GTM to turn scientific proof into buyer-ready messaging across key application areas, with cross-functional alignment and KOL leverage.

  • Segment thesis development and proof-point architecture to guide content and strategy.
  • End-to-end content strategy and data-grounded assets for a skeptical scientific audience.
  • KOL relationships and public-proof points that unlock new markets and channel impact.

Job Description

Responsibilities

  • Segment Narrative and Market Thesis:
  • Develop and maintain application area narratives that articulate the problem, limitations of status quo, Cellanome advantage, supporting proof, and urgency for each market segment.
  • Partner with Corporate Marketing on segment GTM strategy to co-design and align segment-level market theses with Cellanome’s overarching corporate brand, theme calendar, and demand generation engine.
  • Lead presence buildout in key application areas in close partnership with Applications Product Management, R&D, and Scientific Affairs to ensure narratives are scientifically grounded and commercially sharp.
  • Content Development:
  • Drive high-authority content creation by owning the end-to-end segment content strategy and authoring specific, data-grounded assets (including blog posts, application area pages, conference presentations, ROI frameworks, and case studies) tailored for a skeptical scientific audience.
  • Collaborate closely with Corporate Marketing to optimize segment content for high-impact channel distribution, and with Applications and Platform Product Management on launches, competitive positioning, product- and technology- level content and sales enablement.
  • KOL and Scientific Community Relationships:
  • Identify and support key opinion leaders (KOL) & early access placement sites who can open target markets and build relationships that generate credible, public proof points.
  • Structure collaborations and publications to support market adoption in partnership with Collaboration Scientists, Scientific Affairs, the account team s , and leadership.
  • Own the marketing side of select KOL relationships, ensuring visibility and impact of collaborations across channels.
  • Sales Enablement:
  • Develop and maintain segment-specific sales enablement materials including talk tracks, objection handling guides, qualification criteria, and "why now, why us" framing for each application area .
  • Partner with Sales on market development , early funnel building , and specific opportunities as appropriate .
  • Market Intelligence:
  • Maintain a current view of key segment landscapes, shifting market dynamics and customer needs, and emerging application areas.
  • Synthesize intelligence into actionable inputs for Sales, Product, and leadership with clear implications and recommended actions.
  • Strong presentation and communication skills.
  • Ability to travel up to 30% of working time away from work location, may include overnight and/or weekend travel at times.

Requirements

  • Typically requires a minimum of 15 years of related experience with a Bachelor’s degree; or 12 years and a Master’s degree; or a PhD with 8 years experience; or equivalent experience.
  • Deep fluency in immunology, neurobiology, immune-oncology, functional screening, cell biology, single-cell genomics, and/or functional cell assays.
  • Demonstrated ability to build a market narrative from scratch: segment thesis, proof point architecture, and the content stack that moves buyers from awareness to conviction.
  • Exceptional scientific communication skills, with the ability to produce content that working biologists read and trust.
  • Track record of driving cross-functional alignment without direct authority: getting Scientific Affairs, Sales, and Product moving in the same direction on shared evidence and narrative priorities.
  • Experience producing senior-quality output independently, without a large team or agency infrastructure to rely on.
  • Demonstrated ability to perform the essential duties of the position with or without reasonable accommodations.

Preferred

  • Experience building GTM infrastructure for an emerging or nascent category, not just executing playbooks for established markets.
  • Fluency with AI tools as a practical force multiplier for research, drafting, and content production.
  • Experience structuring or influencing scientific collaborations and KOL relationships for commercial or market development purposes.

Benefits

  • comprehensive employment package
  • competitive salary
  • generous stock options
  • great individual and family health plans
  • a 401(k)
  • flexibility to balance work and life
Cellanome logo

Cellanome

Reveal Cellular Choreography | See Biology in Motion Cellanome enables scientists to capture the intricacies of cells and their interactions, with the scale, resolution and context necessary to unravel biological complexity. Our live-cell analysis platform captures cellular dynamics at scale, integrating time-lapse imaging with single-cell transcriptomics to reveal how cells evolve, interact, and respond over time. This generates AI-ready datasets with the context and continuity needed to advance therapeutic development and mechanistic understanding across immunology, oncology, neuroscience, and aging.

Founded in 2020
San Mateo, California, USA
125 employees (2 in marketing)

Traffic Signals

Monthly Visitors
2.7K
Traffic Source Mix
Search
26.8%
Direct
49.1%
Referral
6.1%
Social
16.6%
Paid
1.3%

Headcount Trend

Current headcount: ~125

Marketing Team

Marketing Team Size
2 (2% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$213.7M
Last Raise
$150M
Series B, 2 years ago

Funding History

  • Jan 2024
    Series B • $150M
  • Aug 2022
    Series A • $40.7M
  • Dec 2021
    Series A • $21M